Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | Institution | 1 439 983 | 12,77% | US$ 8,19M | 2026-04-29 |
| OrbiMed Private Investments VI, LP | Institution | 1 218 240 | 10,80% | US$ 6,93M | 2026-04-29 |
| BVF Partners L.P. | Institution | 1 110 002 | 9,84% | US$ 6,32M | 2026-03-31 |
| enGene Therapeutics Inc. | Institution | 971 173 | 8,61% | US$ 5,53M | 2025-07-25 |
| CHI Advisors LLC | Institution | 959 337 | 8,51% | US$ 5,46M | 2026-03-31 |
| Cable Car Capital LLC | Institution | 754 749 | 6,69% | US$ 4,29M | 2026-03-31 |
| Funicular Fund, LP | Institution | 643 933 | 5,71% | US$ 3,66M | 2025-12-29 |
| Biotechnology Value Fund L.P. | Institution | 593 189 | 5,26% | US$ 3,38M | 2026-03-31 |
| Omega Fund Management, LLC | Institution | 455 361 | 4,04% | US$ 2,59M | 2026-03-31 |
| Omega Fund VI, L.P. | Institution | 454 982 | 4,03% | US$ 2,59M | 2026-04-14 |
| Omega Advisors, Inc. | Institution | 454 982 | 4,03% | US$ 2,59M | 2026-04-14 |
| Biotechnology Value Fund II, L.P. | Institution | 433 269 | 3,84% | US$ 2,47M | 2026-03-31 |
| RTW Investments, LP | Institution | 334 445 | 2,97% | US$ 1,90M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 325 155 | 2,88% | US$ 1,85M | 2026-03-31 |
| Atlas Venture Fund X, L.P. | Institution | 241 800 | 2,14% | US$ 1,38M | 2025-07-25 |
| BML Capital Management, LLC | Institution | 200 730 | 1,78% | US$ 1,14M | 2026-03-31 |
| HighLight Capital | Institution | 188 042 | 1,67% | US$ 1,07M | 2025-07-25 |
| Dr. Jonathan Jian Wang | Initiés | 143 832 | 1,28% | US$ 818,40k | 2025-07-25 |
| BlackRock, Inc. | Institution | 129 214 | 1,15% | US$ 735,23k | 2026-03-31 |
| Citadel Advisors LLC | Institution | 124 345 | 1,10% | US$ 707,52k | 2026-03-31 |
| Atlas Venture Fund XI, L.P. | Institution | 103 494 | 0,92% | US$ 588,88k | 2025-07-25 |
| Renaissance Technologies LLC | Institution | 81 696 | 0,72% | US$ 464,85k | 2026-03-31 |
| Atlas Venture Opportunity Fund I | Institution | 72 885 | 0,65% | US$ 414,72k | 2025-07-25 |
| Biotechnology Value Trading Fund OS LP | Institution | 66 808 | 0,59% | US$ 380,14k | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 66 666 | 0,59% | US$ 379,33k | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 59 929 | 0,53% | US$ 341,00k | 2026-03-31 |
| Trails Edge Biotechnology Master Fund, Lp | Institution | 54 253 | 0,48% | US$ 308,70k | 2026-04-14 |
| Trails Edge Capital Partners, LP | Institution | 54 253 | 0,48% | US$ 308,70k | 2026-04-14 |
| HLC GP III Company Limited | Institution | 50 144 | 0,44% | US$ 285,32k | 2025-07-25 |
| New Enterprise Associates, Inc. | Institution | 50 005 | 0,44% | US$ 284,53k | 2026-03-31 |
| HSBC Global Asset Management (UK) Limited | Institution | 34 884 | 0,31% | US$ 198,49k | 2026-03-31 |
| OrbiMed Genesis Master Fund, L.P. | Institution | 33 798 | 0,30% | US$ 192,31k | 2026-04-29 |
| Rangeley Capital, LLC | Institution | 32 590 | 0,29% | US$ 185,44k | 2026-03-31 |
| Sofinnova Investments, Inc. | Institution | 31 884 | 0,28% | US$ 181,42k | 2026-03-31 |
| Nano-Cap New Millennium Advisors, Llc | Institution | 30 000 | 0,27% | US$ 170,70k | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 27 286 | 0,24% | US$ 155,26k | 2026-03-31 |
| Jacobs Levy Equity Management Inc | Institution | 26 663 | 0,24% | US$ 151,71k | 2026-03-31 |
| Shay Capital LLC | Institution | 19 130 | 0,17% | US$ 108,85k | 2026-03-31 |
| Aldebaran Capital, LLC | Institution | 18 566 | 0,16% | US$ 105,64k | 2026-03-31 |
| Mr. Joseph Slattery | Initiés | 16 000 | 0,14% | US$ 91,04k | 2025-12-24 |
| XTX Markets Limited | Institution | 15 112 | 0,13% | US$ 85,99k | 2026-03-31 |
| Hudson River Trading LLC | Institution | 13 909 | 0,12% | US$ 79,14k | 2026-03-31 |
| Jane Street Group, LLC | Institution | 13 210 | 0,12% | US$ 75,16k | 2026-03-31 |
| Prelude Capital Management, LLC | Institution | 12 990 | 0,12% | US$ 73,91k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.